Glycotope Biotechnology - Recombinant Technology - Ownership and Business Overview

Medical ProductsCompany

Glycotope Biotechnology - Recombinant Technology Ownership

Who owns Glycotope Biotechnology - Recombinant Technology?

Glycotope Biotechnology - Recombinant Technology is owned by Octapharma AG. It was acquired on October 8, 2015.

Glycotope Biotechnology - Recombinant Technology Business Overview

Where is Glycotope Biotechnology - Recombinant Technology headquartered?

Glycotope Biotechnology - Recombinant Technology is headquartered in United States.

What sector is Glycotope Biotechnology - Recombinant Technology in?

Glycotope Biotechnology - Recombinant Technology is a medical products company.

Medical Products M&A Summary in 2015

Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2015. The largest medical products acquisition in 2015 was Sirona Dental Systems - which was acquired by Dentsply Sirona for $5.6B.

Join Mergr to view all 266 acquisitions of medical products companies in 2015, including 24 acquisitions by private equity firms, and 242 by strategics.

Glycotope Biotechnology - Recombinant Technology


United States,

Glycotope Biotechnology - Recombinant Technology is a developer of biotechnology products and services.


 Subscribe to unlock this and 203,188
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 195K M&A Transactions
  • 199K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Glycotope Biotechnology - Recombinant Technology

Medical Products Companies , United States Companies